Ali Iranmanesh1, Donna Lawson, Johannes D Veldhuis. 1. Endocrine Research Unit, Mayo School of Graduate Medical Education, Center for Translational Science Activities, Mayo Clinic, Rochester, Minnesota 55905, USA.
Abstract
CONTEXT: GH secretion declines rapidly after glucose ingestion and then recovers to higher-than-baseline levels (rebound GH release). HYPOTHESIS: Selective metabolic markers predict the magnitude of glucose-suppressed GH release and postglucose rebound-like GH secretion. DESIGN: Prospectively randomized crossover study of GH secretion after glucose vs. water ingestion. SETTING: The study was conducted at a clinical translational research center. PARTICIPANTS: Sixty-nine healthy men aged 19-78 yr with a body mass index of 18-39 kg/m(2) participated in the study. OUTCOMES: OUTCOMES included nadir vs. peak GH concentrations and basal vs. pulsatile GH secretion. RESULTS:Mean nadir GH concentrations were determined positively by sex hormone binding globulin (SHBG) after glucose administration (R(2) = 0.088, P = 0.0077). Peak rebound GH concentrations were related positively to adiponectin and negatively to computed tomography-estimated abdominal visceral fat (AVF) (R(2) = 0.182, P = 0.00049) after glucose ingestion. Deconvolution analysis showed that SHBG specifically predicted basal (nonpulsatile) GH secretion after glucose exposure (R(2) = 0.153, P = 0.00052). In contrast, together exercise history and adiponectin (both positively) and AVF (negatively) predicted pulsatile GH escape after glucose suppression (R(2) = 0.206, P = 0.00043). Moreover, adiponectin uniquely determined the size (mass), and AVF the mode (duration), of GH secretory bursts after glucose exposure (both P < 0.006). CONCLUSION: Glucose ingestion provides a clinical model for investigating complementary metabolic surrogates that determine suppression and recovery of basal and pulsatile GH secretion in healthy men.
RCT Entities:
CONTEXT: GH secretion declines rapidly after glucose ingestion and then recovers to higher-than-baseline levels (rebound GH release). HYPOTHESIS: Selective metabolic markers predict the magnitude of glucose-suppressed GH release and postglucose rebound-like GH secretion. DESIGN: Prospectively randomized crossover study of GH secretion after glucose vs. water ingestion. SETTING: The study was conducted at a clinical translational research center. PARTICIPANTS: Sixty-nine healthy men aged 19-78 yr with a body mass index of 18-39 kg/m(2) participated in the study. OUTCOMES: OUTCOMES included nadir vs. peak GH concentrations and basal vs. pulsatile GH secretion. RESULTS: Mean nadir GH concentrations were determined positively by sex hormone binding globulin (SHBG) after glucose administration (R(2) = 0.088, P = 0.0077). Peak rebound GH concentrations were related positively to adiponectin and negatively to computed tomography-estimated abdominal visceral fat (AVF) (R(2) = 0.182, P = 0.00049) after glucose ingestion. Deconvolution analysis showed that SHBG specifically predicted basal (nonpulsatile) GH secretion after glucose exposure (R(2) = 0.153, P = 0.00052). In contrast, together exercise history and adiponectin (both positively) and AVF (negatively) predicted pulsatile GH escape after glucose suppression (R(2) = 0.206, P = 0.00043). Moreover, adiponectin uniquely determined the size (mass), and AVF the mode (duration), of GH secretory bursts after glucose exposure (both P < 0.006). CONCLUSION:Glucose ingestion provides a clinical model for investigating complementary metabolic surrogates that determine suppression and recovery of basal and pulsatile GH secretion in healthy men.
Authors: Christian Berg; Timo Meinel; Harald Lahner; Ali Yuece; Klaus Mann; Stephan Petersenn Journal: Eur J Endocrinol Date: 2009-12-08 Impact factor: 6.664
Authors: R Valcavi; M Zini; C Volta; L Ghizzoni; C Azzarito; S Bernasconi; I Portioli Journal: J Clin Endocrinol Metab Date: 1994-10 Impact factor: 5.958
Authors: Andreas Peter; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Harald Staiger; Fausto Machicao; Erwin Schleicher; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan Journal: Diabetes Date: 2010-09-14 Impact factor: 9.461
Authors: Peter Y Liu; Daniel M Keenan; Petra Kok; Vasantha Padmanabhan; Kevin T O'Byrne; Johannes D Veldhuis Journal: Am J Physiol Endocrinol Metab Date: 2009-06-16 Impact factor: 4.310
Authors: M Maccario; E Arvat; M Procopio; L Gianotti; S Grottoli; B P Imbimbo; V Lenaerts; R Deghenghi; F Camanni; E Ghigo Journal: Metabolism Date: 1995-01 Impact factor: 8.694
Authors: Cyril Y Bowers; Ramona Granda; Subburaman Mohan; Jonathan Kuipers; David Baylink; Johannes D Veldhuis Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: M Maccario; M Procopio; S Grottoli; S E Oleandri; P Razzore; F Camanni; E Ghigo Journal: J Clin Endocrinol Metab Date: 1995-12 Impact factor: 5.958
Authors: Johannes D Veldhuis; Thomas P Olson; Paul Y Takahashi; John M Miles; Michael J Joyner; Rebecca J Yang; Jean Wigham Journal: Metabolism Date: 2015-05-15 Impact factor: 8.694
Authors: Lara Pena-Bello; Sonia Pertega-Diaz; Elena Outeiriño-Blanco; Jesus Garcia-Buela; Sulay Tovar; Susana Sangiao-Alvarellos; Carlos Dieguez; Fernando Cordido Journal: PLoS One Date: 2015-03-17 Impact factor: 3.240
Authors: Christian-Heinz Anderwald; Andrea Tura; Alois Gessl; Sabina Smajis; Christian Bieglmayer; Rodrig Marculescu; Anton Luger; Giovanni Pacini; Michael Krebs Journal: PLoS One Date: 2014-12-17 Impact factor: 3.240